Lotemax Suspension/ Drops
Product Images NDC 24208-299

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lotemax (NDC 24208-299). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bausch & Lomb Incorporated, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

503e8dec 527b 419a 858d Ef038ce3cf5e 00

Lotemax 0.5% (loteprednol etabonate) ophthalmic suspension sterile drops in a 15 mL bottle, labeled for prescription use only. The packaging shows Bausch & Lomb Incorporated as the labeler and manufacturer. The label includes storage instructions, usage warnings, inactive ingredients, and a note to shake vigorously before use. Product of France.*

FDA Label Image

Loteprednol Etabonate (structural Formula) (760eeae1 6004 4314 9b29 1f7d434714cf 01)

Chemical structure of loteprednol etabonate, depicted with its steroid nucleus and functional groups including hydroxyl, ketone, and ester moieties.*

FDA Label Image

Symbol (760eeae1 6004 4314 9b29 1f7d434714cf 02)

LOTEMAX loteprednol etabonate 5 mg/mL ophthalmic suspension in a white plastic bottle with a white screw cap. The label includes the brand and generic names, strength, dosage form, route of administration, and the Bausch & Lomb Incorporated labeler information. The product NDC 24208-299 is visible on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.